Aurora Cannabis Inc is facing a downturn in its stock price, reflecting investor concerns despite recent revenue growth.
Aurora Cannabis Inc (ACB.TO) is experiencing a notable decline in its stock price, down 3.35% to CA$5.19 in today's trading session. This drop comes despite the company's recent announcement of a 17% year-over-year increase in international medical cannabis revenue for the first quarter of fiscal 2027.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$315.90M
52W high
$9.33
52W low
$3.59
1W change
+1.51%
Beta
1.34
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 3.5% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.56
+3.5% Upside
Current Price
C$5.37
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
72.1%
Annualized
90-Day Vol
61.8%
Annualized
Trend (90d)
+39.3%
Annualized drift
90d Mean
C$6.18
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$5.63 | C$4.39 โ C$7.22 |
| 60 trading days | C$5.90 | C$4.15 โ C$8.39 |
| 90 trading days | C$6.18 | C$4.02 โ C$9.51 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Aurora Cannabis faces volatility, even amid positive revenue reports.
Aurora Cannabis Inc stock down 3.35% today
Despite a strong balance sheet with no debt and $149.1 million in cash, investor sentiment remains weak, impacting stock performance.
Bull case
Aurora's recent revenue growth and EU-GMP certification could set the stage for future international expansion. This certification enhances their credibility and ability to tap into new markets, which could lead to increased sales and profits down the line.
Bear case
The stock's decline today highlights ongoing investor skepticism. This uncertainty may stem from broader market conditions or worries about the company's profitability. Investors are weighing the potential for growth against these persistent challenges, which could keep the stock under pressure.
Stock Performance Overview
Advertisement
Aurora Cannabis Inc's stock has seen a decline of 3.35% in today's trading, closing at CA$5.19. This drop comes as a surprise to some investors, given the company's recent announcement of a significant increase in revenue.
Recent Company Developments
Aurora recently reported a 17% year-over-year increase in international medical cannabis net revenue, totaling CA$67.6 million for the first quarter of fiscal 2027. Additionally, the company secured a three-year EU-GMP certification for its Safari Flower Company, which is expected to enhance its ability to supply international markets.
Investor Sentiment and Market Reaction
Despite the positive revenue news, investor sentiment appears to be cautious, as reflected in the stock's performance today. The cannabis sector continues to face volatility, and Aurora's stock movement suggests that investors are weighing the company's growth potential against ongoing market challenges.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
